Search Results

There are 876477 results for: content related to: Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Version of Record online : 23 FEB 2012, DOI: 10.1002/pds.3219

  3. Exploring the effect of erythropoietin on mortality using USRDS data

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 593–606, Wei Yang, Marshall M. Joffe and Harold I. Feldman

    Version of Record online : 1 MAY 2013, DOI: 10.1002/pds.3452

  4. Drug-induced Stevens–Johnson syndrome: case series from tertiary care centre in Gujarat

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 384–395, Damodar Bang, Tapan Shah, Divyesh Thakker, Yogesh Shah and Amit D. Raval

    Version of Record online : 28 FEB 2012, DOI: 10.1002/pds.3212

  5. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pds.3234

  6. Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 524–534, Sengwee Toh, Lingling Li, Leslie R. Harrold, Elizabeth A. Bayliss, Jeffrey R. Curtis, Liyan Liu, Lang Chen, Carlos G. Grijalva and Lisa J. Herrinton

    Version of Record online : 13 MAR 2012, DOI: 10.1002/pds.3238

  7. Relative safety of peginesatide and epoetin alfa

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 10, October 2014, Pages: 1003–1011, Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins and Robert N. Foley

    Version of Record online : 6 JUN 2014, DOI: 10.1002/pds.3655

  8. Use of multiple sources and capture–recapture method to estimate the frequency of hospitalizations related to drug abuse

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 7, July 2012, Pages: 733–741, Emilie Jouanjus, Laure Pourcel, Sylvie Saivin, Laurent Molinier and Maryse Lapeyre-Mestre

    Version of Record online : 2 MAY 2012, DOI: 10.1002/pds.3280

  9. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 835–843, Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert and Olaf H. Klungel

    Version of Record online : 6 JUN 2012, DOI: 10.1002/pds.3291

  10. Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 470–484, Hae Sun Suh, Joel W. Hay, Kathleen A. Johnson and Jason N. Doctor

    Version of Record online : 28 MAR 2012, DOI: 10.1002/pds.3261

  11. Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 12, December 2012, Pages: 1251–1260, Stacie B. Dusetzina, Alisa B. Busch, Rena M. Conti, Julie M. Donohue, G. Caleb Alexander and Haiden A. Huskamp

    Version of Record online : 3 MAY 2012, DOI: 10.1002/pds.3272

  12. A critical review of methods to evaluate the impact of FDA regulatory actions

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 986–994, Becky A. Briesacher, Stephen B. Soumerai, Fang Zhang, Sengwee Toh, Susan E. Andrade, Joann L. Wagner, Azadeh Shoaibi and Jerry H. Gurwitz

    Version of Record online : 12 JUL 2013, DOI: 10.1002/pds.3480

  13. You have free access to this content
    Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S2, May 2012, Pages: 99–113, Romain Neugebauer, Bruce Fireman, Jason A. Roy, Patrick J. O'Connor and Joe V. Selby

    Version of Record online : 3 MAY 2012, DOI: 10.1002/pds.3253

  14. Uses of proton pump inhibitors and hypomagnesemia

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 553–559, Jen-Tzer Gau, Yu-Xiao Yang, Roger Chen and Tzu-Cheg Kao

    Version of Record online : 15 FEB 2012, DOI: 10.1002/pds.3224

  15. You have free access to this content
    Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S2, May 2012, Pages: 60–68, Menggang Yu, Dawei Xie, Xingmei Wang, Mark G. Weiner and Richard L. Tannen

    Version of Record online : 3 MAY 2012, DOI: 10.1002/pds.3235

  16. Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 872–880, Olesya I. Zorina, Patrick Haueis, Alexander Semmler, Isabelle Marti, Roman R. Gonzenbach, Markus Guzek, Gerd A. Kullak-Ublick, Michael Weller and Stefan Russmann

    Version of Record online : 19 APR 2012, DOI: 10.1002/pds.3279

  17. Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

    Intervention Review

    The Cochrane Library

    Julia Bohlius, Kurt Schmidlin, Corinne Brillant, Guido Schwarzer, Sven Trelle, Jerome Seidenfeld, Marcel Zwahlen, Mike J Clarke, Olaf Weingart, Sabine Kluge, Margaret Piper, Maryann Napoli, Dirk Rades, David Steensma, Benjamin Djulbegovic, Martin F Fey, Isabelle Ray-Coquard, Volker Moebus, Gillian Thomas, Michael Untch, Martin Schumacher, Matthias Egger and Andreas Engert

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD007303.pub2

  18. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Version of Record online : 17 JUN 2014, DOI: 10.1002/pds.3663

  19. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Version of Record online : 10 MAY 2014, DOI: 10.1002/pds.3634

  20. The non-linear threshold association between aspirin use and esophageal adenocarcinoma: results of a dose–response meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 278–284, Ye Xiaohua, Yao Zhenjiang, Liu Weidong, Xun Pengcheng and Chen Sidong

    Version of Record online : 17 JAN 2014, DOI: 10.1002/pds.3560